v10153
Recombinant proteinexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2005 (NCT00144014)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tissue-type plasminogen activatorSupplementation
PLAT supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- v10153
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00144014 | Phase 2 | Aug 1, 2005 | University of Calgary, Vernalis |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Calgary | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Vernalis | For profit | 1 | 1 | 1 | 2005 |
2 organizations
Page 1 / 1